Glyceraldehyde-3-phosphate dehydrogenase versus toluidine blue as a marker for infarct volume estimation following permanent middle cerebral artery occlusion in mice

Experimental Brain Research

Volumn 175, Issue 1, 2006, Pages 60-67

  Clausen, Bettina H ^a   Lambertsen, Kate L ^a   Finsen, Bente ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cerebral infarction; Focal cerebral ischemia; Histology; Infarct volume estimation; Mice

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TOLONIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; EUTHANASIA; FROZEN SECTION; HISTOLOGY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; STAINING; STROKE;

ANIMALS; BRAIN INFARCTION; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; IN SITU HYBRIDIZATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; STATISTICS, NONPARAMETRIC; TIME FACTORS; TOLONIUM CHLORIDE;

EID: 33749625957     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-006-0526-3     Document Type: Article

References (33)

1. Altman FP (1976) Tetrazolium salts and formazans. Prog Histochem Cytochem 9:1-56
2. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM (1986) Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308
3. Berry MD (2004) Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders. J Psychiatr Neurosci 29:337-345
4. Carlile GW, Chalmers-Redman RM, Tatton NA, Pong A, Borden KE, Tatton WG (2000) Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol Pharmacol 57:2-12
5. Chen RW, Saunders PA, Wei H, Li Z, Seth P, Chuang DM (1999) Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53. J Neurosci 19:9654-9662
6. Clausen BH, Lambertsen KL, Meldgaard M, Finsen B (2005) A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 132:879-892
7. Dastoor Z, Dreyer JL (2001) Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J Cell Sci 114:1643-1653
8. Gregersen R, Lambertsen K, Finsen B (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20:53-65
9. Hatfield RH, Mendelow AD, Perry RH, Alvarez LM, Modha P (1991) Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol Appl Neurobiol 17:61-67
10. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang DM (1996) Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 66:928-935
11. Ishitani R, Tajima H, Takata H, Tsuchiya K, Kuwae T, Yamada M, Takahashi H, Tatton NA, Katsube N (2003) Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs. Prog Neuropsychopharmacol Biol Psychiatr 27:291-301
12. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM (1998) Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53:701-707
13. Joshi CN, Jain SK, Murthy PS (2004) An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Brain Res Protoc 13:11-17
14. Kharlamov A, Kim DK, Jones SC (2001) Early visual changes in reflected light on non-stained brain sections after focal ischemia mirror the area of ischemic damage. J Neurosci Methods 111:67-73
15. Kloss CU, Thomassen N, Fesl G, Martens KH, Yousri TA, Hamann GF (2002) Tissue-saving infarct volumetry using histochemistry validated by MRI in rat focal ischemia. Neurol Res 24:713-718
16. Lambertsen KL, Gregersen R, Drojdahl N, Owens T, Finsen B (2001) A specific and sensitive method for visualization of tumor necrosis factor in the murine central nervous system. Brain Res Brain Res Protoc 7:175-191
17. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B (2005) A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25:119-135
18. Liszczak TM, Hedley-Whyte ET, Adams JF, Han DH, Kolluri VS, Vacanti FX, Heros RC, Zervas NT (1984) Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol (Berl) 65:150-157
19. Moller A, Christophersen P, Drejer J, Axelsson O, Peters D, Jensen LH, Nielsen EO (1995) Pharmacological profile and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Neurol Res 17:353-360
20. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA (2003) Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140:471-476
21. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, Graham DI (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatr 50:402-410
22. Pettigrew LC, Holtz ML, Craddock SD, Minger SL, Hall N, Geddes JW (1996) Microtubular proteolysis in focal cerebral ischemia. J Cereb Blood Flow Metab 16:1189-1202
23. Relton JK, Martin D, Thompson RC, Russell DA (1996) Peripheral administration of Interleukin-1 receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Exp Neurol 138:206-213
24. Saunders PA, Chalecka-Franaszek E, Chuang DM (1997) Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem 69:1820-1828
25. Sawa A, Khan AA, Hester LD, Snyder SH (1997) Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 94:11669-11674
26. Shashidharan P, Chalmers-Redman RM, Carlile GW, Rodic V, Gurvich N, Yuen T, Tatton WG, Sealfon SC (1999) Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. Neuroreport 10:1149-1153
27. Sirover MA (1997) Role of the glycolytic protein, glyceraldehyde-3- phosphate dehydrogenase, in normal cell function and in cell pathology. J Cell Biochem 66:133-140
28. Sirover MA (1999) New insight into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432:159-184
29. Tanaka R, Mochizuki H, Suzuki A, Katsube N, Ishitani R, Mizuno Y, Urabe T (2002) Induction of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression in rat brain after focal ischemia/reperfusion. J Cereb Blood Flow Metab 22:280-288
30. Taylor R, Luk YO, Chen ST, Balentine JD, Hogan EL, Hsu CY, Charleston SC (1987) Quantification of infarct area by triphenyltetrazolium chloride in a rat model. Neurology 37:82
31. Vogel J, Mobius C, Kuschinsky W (1999) Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining. Stroke 30:1134-1141
32. Xu KY, Zweier JL, Becker LC (1995) Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res 77:88-97
33. Zivin JA (1998) Factors determining the therapeutic window for stroke. Neurology 50:599-603